Renowned Industry Leader John Burns Announced as Keynote Speaker for BIA Outlook 2024 Economic Forecast Event
IRVINE, Calif.–(BUSINESS WIRE)–The Building Industry Association of Southern California (BIASC) today announced that John Burns of John Burns Research... Read more.
Universal ID Council (UIDC) Launches to Address the Global Identification Crisis
Former World Bank Executive Dr. Mariana Dahan Announces New Initiative at Davos 2024 Forum, Advocating for a Universal ID Program and Fair Access to Financial Services... Read more.
Traffic Management Systems Market Forecasted to Reach $50.20 Billion by 2030 with High-Growth in Asia-Pacific Region – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Traffic Management Systems Market by Offering, Deployment, Technology & Geography – Global Forecasts to 2030”... Read more.
Registration Opens for DeviceTalks Boston 2024
Medical Device Leaders to Gather at DeviceTalks Boston on May 1-2 BOSTON–(BUSINESS WIRE)–#medicaldevice–DeviceTalks, a leading multimedia content... Read more.
ITT Completes Acquisition of Svanehøj, Leading Provider of Customized Critical Liquid and Cryogenic Pumps
STAMFORD, Conn.–(BUSINESS WIRE)–January 19, 2024– ITT Inc. (NYSE: ITT) today announced the completion of its acquisition of Svanehøj Group A/S... Read more.
Conceal Announces Expansion into Southeast Asia with Nordic Solutions Partnership
Conceal partners with Nordic Solutions to integrate its sophisticated ConcealBrowse technology, enhancing Nordic Solution’s proactive and responsive offerings... Read more.
INFICON Acquires all Assets of Smart Manufacturing Software Specialist FabTime
BAD RAGAZ, Switzerland–(BUSINESS WIRE)–#FDC–INFICON strengthens its position as a provider of semiconductor Smart manufacturing software with the... Read more.
Global Cloud-native Application Protection Platform Market – Increasing Requirements for Code to Cloud Security Drive CNAPP Growth Potential – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Global Cloud-native Application Protection Platform Growth Opportunities” report has been added to ResearchAndMarkets.com’s... Read more.
IMFINZI® (durvalumab) plus transarterial chemoembolization (TACE) and bevacizumab reduced the risk of disease progression or death by 23% vs. TACE in liver cancer eligible for embolization
EMERALD-1 is first global Phase III trial to show improved clinical outcome for systemic therapy in combination with TACE in this setting WILMINGTON, Del.–(BUSINESS... Read more.
Natixis Investment Managers Sponsors World-Class Para Athlete Femita Ayanbeku
BOSTON–(BUSINESS WIRE)–Natixis Investment Managers (Natixis IM) today announced its sponsorship of elite US amputee sprinter Femita Ayanbeku. Boston-native... Read more.